Derrick Guo - Novadaq Technologies General Counsel
| NVDQ Etf | 5.64 0.53 8.59% |
Mr. Derrick Guo is General Counsel, Corporationrationrate Secretary of the company. Mr. Guo joined NOVADAQ in 2014 as Corporationrationrate Counsel and has served as General Counsel and Corporationrationrate Secretary since 2015. In this role, Mr. Guo oversees NOVADAQs global legal activities and policies, as well as ethics and compliance. Prior to joining NOVADAQ, Mr. Guo was a corporate lawyer at Stikeman Elliott from 2007 to 2014, serving as external counsel to NOVADAQ during such time, with a focus on securities law, mergers and acquisitions, and commercial and corporate law. Mr. Guo is also a chartered accountant and worked at PriceWaterhouseCoopers LLP from 2000 2004. Mr. Guo is a member of the Law Society of Upper Canada and a member of the Chartered Professional Accountants of Ontario
| Tenure | 9 years |
| Address | 5090 Explorer Drive, Suite 202 L4W 4TW,Mississauga,CAN |
| Phone | 905-629-3822 |
| Web | www.novadaq.com |
| Issuer | Tuttle Capital Management |
| Inception Date | 2023-10-19 |
| Entity Type | Regulated Investment Company |
| Asset Type | Equity |
| Category | Strategy |
| Focus | Single Stock |
| Market Concentration | Developed Markets |
| Region | North America |
| Administrator | Commonwealth Fund Services, Inc. |
| Advisor | Tuttle Capital Management, LLC |
Similar Fund Executives
| Showing other executives | One Year Return | ||
| Christine McCauley | Edwards Lifesciences Corp | 59 | |
| Marc Nash | Outset MedicalInc | 35 | |
| John Saia | Guardant Health | 51 | |
| Leena DasYoung | Guardant Health | N/A | |
| Anna Georgiadis | Venus Concept | 53 | |
| Mary Picerno | Cigna Corp | N/A | |
| Alexis Jones | Cigna Corp | N/A | |
| Jennifer Chaloemtiarana | Doximity | 56 | |
| Lee Wood | Mednax Inc | 55 | |
| Megan MPH | Laboratory of | N/A | |
| Craig Hazenfield | Definitive Healthcare Corp | N/A | |
| Dirksen Lehman | Edwards Lifesciences Corp | N/A | |
| Michael Wiley | Guardant Health | 42 | |
| Jonathan DiVincenzo | Laboratory of | 58 | |
| Mark MS | Outset MedicalInc | 67 | |
| Matt Ruderman | Definitive Healthcare Corp | N/A | |
| Phil Austin | Cigna Corp | N/A | |
| Darl Moreland | Guardant Health | 65 | |
| Mark Jacobstein | Guardant Health | N/A | |
| Clarissa Willett | Laboratory of | N/A | |
| William McGrail | Venus Concept | 63 | |
Novadaq Technologies Money Managers
| Anthony Griffiths, Independent Non-Executive Chairman of the Board | ||
| Patrice Merrin, Director | ||
| Lori Swalm, VP of Marketing | ||
| Thomas Wellner, Independent Director | ||
| Lisa Colleran, Director | ||
| Arun Menawat, President CEO, Director | ||
| Rick Mangat, Co-Founder, Sr. VP and General Manager | ||
| Harold Koch, Independent Director | ||
| David Martin, IR Contact Officer | ||
| Robert White, Director | ||
| Karen Licitra, Director | ||
| Aaron Davidson, Independent Director | ||
| Derrick Guo, General Counsel | ||
| William MacKinnon, Independent Director | ||
| Roger Deck, Vice President - Operations |
Novadaq Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is Novadaq Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Price To Earning | (12.09) X | ||||
| Revenue | 80.07 M | ||||
| EBITDA | (50.47 M) | ||||
| Net Income | (52.91 M) | ||||
| Cash And Equivalents | 49.59 M | ||||
| Cash Per Share | 0.86 X | ||||
| Total Debt | 250 K | ||||
| Debt To Equity | 10.70 % | ||||
| Current Ratio | 3.49 X | ||||
| Book Value Per Share | 1.54 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Novadaq Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Novadaq Technologies' short interest history, or implied volatility extrapolated from Novadaq Technologies options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novadaq Technologies. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Novadaq Etf, please use our How to Invest in Novadaq Technologies guide.Note that the Novadaq Technologies information on this page should be used as a complementary analysis to other Novadaq Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
The market value of Novadaq Technologies is measured differently than its book value, which is the value of Novadaq that is recorded on the company's balance sheet. Investors also form their own opinion of Novadaq Technologies' value that differs from its market value or its book value, called intrinsic value, which is Novadaq Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novadaq Technologies' market value can be influenced by many factors that don't directly affect Novadaq Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novadaq Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Novadaq Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novadaq Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.